Zoetis | ZTS - Current Liabilities


Zoetis reported $2.68B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
AbbVie USD 43.1B 1.46B Sep/2026
Align Technology USD 1.91B 4.9M Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Coherus Biosciences USD 75.51M 56.82M Jun/2026
Dentsply International USD 1.22B 32M Sep/2026
Eli Lilly USD 47B 745M Sep/2026
Henry Schein USD 3.6B 110M Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Illumina USD 1.16B 422M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
J&J USD 55.46B 562M Sep/2026
Laboratory Of America USD 2.82B 695M Sep/2026
Merck USD 28.8B 1.07B Sep/2026
Neogen USD 149.5M 8.7M Jun/2026
Pacira USD 126.1M 4.08M Sep/2026
Perrigo USD 1.02B 34.4M Sep/2026
Pfizer USD 31.73B 920M Sep/2026
Phibro Animal Health USD 295.79M 20.68M Sep/2026
Quest Diagnostics USD 1.83B 46M Sep/2026
Sanofi EUR 29.77B 2.16B Sep/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Zoetis USD 2.68B 621M Sep/2026